Genius Terminal vs Mira — how do they compare? Genius Terminal trades at Rp6,608 (market cap Rp2,2T, Rp212,21M 24h volume), while Mira trades at Rp700.16 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: Genius Terminal is far larger — about 9821× Mira's market cap, and Genius Terminal's circulating supply is 335,4M / 1B GENIUS (34%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Genius Terminal for 5 Days and Mira for 22 Days on average.
| GENIUS | MIRA | |
|---|---|---|
Market Cap | Rp2,2T | Rp224,01M |
Volume (24h) | Rp212,21M | Rp102,95M |
Circulating Supply | 335,4M / 1B GENIUS (34%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 5 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
GENIUS is trading at Rp6,861.63 with strong bullish momentum, showing a market cap of Rp2.31 trillion. Technical indicators signal bullish moving averages but neutral oscillators, with RSI levels suggesting potential overbought conditions. The token maintains a 34% circulation rate with a maximum supply of 1 million tokens. Current price sits between support at Rp6,684 and resistance at Rp7,246, indicating potential for continued upward movement if key levels hold.
Overall outlook remains cautiously optimistic with strong technical momentum but limited fundamental developments. Key opportunities include potential breakout above resistance levels, while major risks involve overbought RSI conditions and limited circulating supply affecting liquidity. Investors should monitor volume patterns and ecosystem developments closely.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
GENIUS is the native asset of Genius Terminal, a platform that uses artificial intelligence to help users research, analyze, and navigate crypto markets. The ecosystem provides tools for market intelligence, project discovery, and information analysis, aiming to streamline how users interact with digital asset data.
Read more on GENIUS →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →